Nicolas Gendron on The Emerging Role of CLIA in The Diagnosis Strategy for HIT
Nicolas Gendron, Research Fellow, Hematologist at Boston Children’s Hospital, shared a proud post on LinkedIn:
”New online publication in Blood VTH, Blood Journals Portfolio
Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin treatments.
Its rapid and reliable diagnosis is essential to adapt management and improve the prognosis of patients.
At the HEGP, we compared the diagnostic performance for the detection of anti-PF4/H antibodies of the HemosIL AcuStar HIT-IgG test (CLIA, Werfen ) with that of our Zymutest HIA IgG reference test (ELISA, HYPHEN BioMed ), in 113 patients suspected of TIH (score 4Ts >3), taking as a reference the result of the platelet function test by radiolabeled serotonin release (RAS).
Excellent sensitivity and specificity of both tests
- Very few discordant cases among patients with confirmed HIT
- Overall agreement between the two techniques: 91.2%
- CLIA has proven to be reliable, fast and efficient
These findings support the use of CLIA as a rapid and relevant diagnostic tool in the diagnosis strategy for HIT
Congratulations to Carla Rial and everyone involved in this great collaborative work!
Shaya Sable, Christine Le Beller, Aurélie Sarthou, Mauge Laetitia, Justine Piazza, Roya Nili Maude Laney, Isabelle Presot Jean-Luc Diehl, Agnès Lillo-Le Louet, Anne Godier, David Smadja, Helley-Russick Dominique
Paris Cardiovascular Research Center – PARCC
Université Paris Cité Faculté de Santé – Université Paris Cité
Université Paris Cité Médecine Greater Paris University Hospitals – AP-HP
Werfen Werfen North America”
Read the full article in Blood VTH.
Article: Evaluation of a chemiluminescent immunoassay IgG anti-PF4/H in the Diagnosis of Heparin-Induced Thrombocytopenia
Authors: Carla Rial, Nicolas Gendron, Christine Le Beller, Shaya Sable, Aurélie Sarthou, Laetitia Mauge, Justine Piazza, Roya Nili, Maude Laney, Isabelle Presot, Jean-Luc Diehl, Anne Godier, Agnès Lillo-Le Louet, David M. Smadja, Dominique Helley

Stay updated on the latest scientific advances in the field of platelet disorders with Hemostasis Today.
-
May 6, 2026, 12:53Masoabi Sefojane: In Africa 88% of Hemophilia Remains Undiagnosed
-
May 6, 2026, 12:36Alan Nurden: CRISPR-Mediated Megakaryocyte Modeling in Glanzmann Thrombasthenia
-
May 6, 2026, 12:12Mona Ranade: Insights from a Medeloop Analytics Study Evaluate Catheter-Directed Therapy in Pulmonary Embolism
-
May 6, 2026, 11:50Natalie L. Baggio: A 24/7 Neurointerventional Stroke Care at Corewell Health Is Now a Reality
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?